• Drug Coverage
  • Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Safety & Recalls
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

WellPoint becomes Medicaid giant

Article

Clearly this is WellPoint's vote of confidence in the future Medicaid market

With its announced acquisition of Amerigroup, WellPoint will become the largest managed care Medicaid organization in the United States. The addition of 2 million Amerigroup members will bring its total Medicaid membership to 4.5 million.

Observers believe the price offered by WellPoint sealed the deal. Otherwise, Amerigroup itself would have been in a good position to grow in the next three to five years.

The Medicaid market previously was labeled to grow by 17 million members thanks to health reform expansion, however, the revised expansion forecast still faces many variables of uncertainty. With states having the option to skip the expansion, new Medicaid coverage could fall short of early expectations.

Another source of Medicaid growth could come from a coincidental awareness among the currently eligible who are not enrolled. The insurance exchanges are meant to facilitate enrollment and could actually inspire more of the current population to come out of the woodwork.

In Ohio for example, the governor expects 165,000 kids and 153,500 adults who are currently eligible but not enrolled to make their way to the exchanges and sign up.

Related Videos
Video 1 - "Demodex Blepharitis: Prevalence, Symptoms, Quality of Life Impact, and Diagnosis"
Video 2 - "The Role of Ruxolitinib in Managing Hydroxyurea Resistance or Intolerance"
Video 1 - "Prevalence and Impact of Hydroxyurea Intolerance or Resistance in Polycythemia Vera"
Video 8 - "Risk and Value-Based Contracting for Prescription Drug Therapeutics and Manufacturer’s Support in Utilization"
Video 7 - "Prescribing Prescription Drug Therapeutics: Factors for Providers and Payers to Consider"
Video 9 -"Overcoming Implementation Barriers for Digital Therapeutics Adoption"
Related Content
© 2024 MJH Life Sciences

All rights reserved.